Home The Word Brain My Amedeo FAQ Privacy About


Hanzi Hunter

Learning 500 Chinese characters in 30 days is possible.

Abstract • About

  Osteoporosis

  Free Subscription


Articles published in J Bone Miner Res

Retrieve available abstracts of 204 articles:
HTML format



Single Articles


    April 2026
  1. JAISWAL R, Larsson BAM, Aberg M, Johansson L, et al
    Serum albumin and the Prognostic Nutritional Index independently predict fracture risk in elderly women.
    J Bone Miner Res. 2026 Apr 2:zjag063. doi: 10.1093.
    PubMed     Abstract available


  2. GULIYEVA G, Takile FNF, Stallfort V, Derer A, et al
    AnnexinA1-Dectin 1 axis is a key regulator of osteoclastogenesis underlying irradiation induced bone loss in male mice.
    J Bone Miner Res. 2026 Apr 2:zjag062. doi: 10.1093.
    PubMed     Abstract available


    March 2026
  3. LUAN S, Morgan EF
    From imaging to insight: biomechanical CT for fracture risk prediction.
    J Bone Miner Res. 2026 Mar 21:zjag040. doi: 10.1093.
    PubMed    


  4. FERRARI S, Thouverey C, Gerbaix M
    Mechanisms Underlying the Waning of Osteoanabolic Therapy Effects in Osteoporosis.
    J Bone Miner Res. 2026 Mar 17:zjag053. doi: 10.1093.
    PubMed     Abstract available


  5. KIWEEWA FM, Lewis L, Stranix-Chibanda L, Dadabhai S, et al
    Recovery in bone mineral density following recent repeat pregnancy and breastfeeding among African women with and without HIV.
    J Bone Miner Res. 2026 Mar 16:zjag021. doi: 10.1093.
    PubMed     Abstract available


  6. WANG X, Leslie WD, Lix LM, Alexiuk MR, et al
    Associations of Osteoporosis, Sarcopenia, and Osteosarcopenia With Mortality: A Comparative Analysis for Different Sarcopenia Definitions in the Manitoba and NHANES Populations.
    J Bone Miner Res. 2026 Mar 12:zjag050. doi: 10.1093.
    PubMed     Abstract available


  7. YE C, Morin SN, Lix LM, McCloskey EV, et al
    Predicting Fracture Risk After Non-Recent High Risk Fracture: Improving accuracy with simple modifiers to FRAX.
    J Bone Miner Res. 2026 Mar 11:zjag049. doi: 10.1093.
    PubMed     Abstract available


  8. YE C, Leslie WD, Al-Azazi S, Yan L, et al
    A Population-Based Cohort Study of Fracture Risk Among 122,255 Adults Before and After Cancer Diagnosis Compared with Matched Controls.
    J Bone Miner Res. 2026 Mar 10:zjag048. doi: 10.1093.
    PubMed     Abstract available


    February 2026
  9. SCHINI M, Paggiosi MA, Gossiel F, Cummings SR, et al
    Expected change: a new concept for monitoring patients on oral bisphosphonates.
    J Bone Miner Res. 2026 Feb 23:zjag039. doi: 10.1093.
    PubMed     Abstract available



  10. Retraction of: Comparative cardiovascular safety of romosozumab versus bisphosphonates in Japanese patients with osteoporosis: a new-user, active comparator design with instrumental variable analyses.
    J Bone Miner Res. 2026 Feb 22:zjaf200. doi: 10.1093.
    PubMed    


  11. ELAM RE, Li J, Paul A, Kersey E, et al
    Performance of U.S.- FRAX TM by Race and Ethnicity for Short-term Hip and Major Osteoporotic Fracture Prediction in U.S. Women with Rheumatoid Arthritis.
    J Bone Miner Res. 2026 Feb 17:zjag033. doi: 10.1093.
    PubMed     Abstract available


  12. ZOULAKIS M, Ambjorn M, Jaiswal R, Axelsson KF, et al
    Impact of Current and Previous Smoking on Fracture Risk in Older Women: The Role of Physical Function, Bone Density and Bone Microarchitecture.
    J Bone Miner Res. 2026 Feb 10:zjag028. doi: 10.1093.
    PubMed     Abstract available


  13. CAULEY JA, Cawthon PM, Ensrud K, Fink HA, et al
    The Osteoporotic Fractures in Men Study (MrOS): a 25-year landmark study of skeletal health in older men.
    J Bone Miner Res. 2026 Feb 5:zjag022. doi: 10.1093.
    PubMed     Abstract available


  14. YU T, Strotmeyer ES, Heilmann NZ, Kado DM, et al
    Leg Power and Velocity Predict the Risk of Major Osteoporotic Fractures (MOF): the Osteoporotic Fractures in Men (MrOS) Study.
    J Bone Miner Res. 2026 Feb 4:zjag014. doi: 10.1093.
    PubMed     Abstract available


  15. BROWN JP
    Concurrent administration of teriparatide and denosumab: attenuation of bone accrual? Editorial on "Comparative Bone Histomorphometry Effects of Combined Denosumab and Teriparatide versus Monotherapy in Postmenopausal Women with Osteoporosis: A Random
    J Bone Miner Res. 2026 Feb 3:zjag023. doi: 10.1093.
    PubMed    


    January 2026
  16. LEBOFF MS, Chou SH, Ratnarajah DM, Cook NR, et al
    The Effects of Marine Fatty Acid Omega-3 Supplements on Incident Fractures and Bone Mineral Density in Generally Healthy Adults.
    J Bone Miner Res. 2026 Jan 28:zjaf172. doi: 10.1093.
    PubMed     Abstract available


  17. VILACA T, Schini M, Lui LY, Ewing SK, et al
    Response to Letter to the Editor Regarding "The relationship between treatment-related changes in total hip BMD measured after 12, 18, and 24 mo and fracture risk reduction in osteoporosis clinical trials: the FNIH-ASBMR-SABER project".
    J Bone Miner Res. 2026 Jan 19:zjag006. doi: 10.1093.
    PubMed    


  18. GARZON EM
    Letter to the Editor Regarding "The relationship between treatment-related changes in total hip BMD measured after 12, 18, and 24 months and fracture risk reduction in osteoporosis clinical trials: the FNIH-ASBMR-SABRE project".
    J Bone Miner Res. 2026 Jan 16:zjag005. doi: 10.1093.
    PubMed    


    December 2025
  19. BUGBIRD AR, Burghardt AJ, Langsetmo L, Ensrud KE, et al
    External validation of a novel HR-pQCT based fracture risk assessment tool (FRAC) in a Male Cohort: The Osteoporotic Fractures in Men (MrOS) Study.
    J Bone Miner Res. 2025 Dec 31:zjaf187. doi: 10.1093.
    PubMed     Abstract available


  20. HEILMANN NZ, Freeland KS, Yu T, Caserotti P, et al
    Associations of Muscle Strength and Functional Power with Longitudinal Change in HR-pQCT Bone Parameters: The Osteoporotic Fractures in Men (MrOS) Study.
    J Bone Miner Res. 2025 Dec 18:zjaf188. doi: 10.1093.
    PubMed     Abstract available


  21. CHO SW, Hong N, Monchka BA, Kimelman D, et al
    Spine age derived from DXA VFA images predicts incident fractures and mortality: the Manitoba Bone Mineral Density Registry.
    J Bone Miner Res. 2025 Dec 18:zjaf194. doi: 10.1093.
    PubMed     Abstract available


  22. MULCRONE JE, Seide K, Chacko J, Carter EM, et al
    Combined Treatment with a C-Type Natriuretic Peptide Analog and Bisphosphonate Enhances Bone Growth in Growing Mice with Osteogenesis Imperfecta: A Pilot Study.
    J Bone Miner Res. 2025 Dec 11:zjaf190. doi: 10.1093.
    PubMed     Abstract available


    November 2025
  23. Q A M, M L B, Scheller EL
    Countering Bone Loss and Marrow Fat Expansion in the Race to Mars.
    J Bone Miner Res. 2025 Nov 17:zjaf170. doi: 10.1093.
    PubMed    


  24. LEIS AM, Jepsen KJ, Bigelow E, Goulet RW, et al
    Trajectories of Areal Bone Mineral Density Significantly Differ by Patterning of Femoral Neck Area and Bone Mineral Content Across the Menopausal Transition.
    J Bone Miner Res. 2025 Nov 13:zjaf162. doi: 10.1093.
    PubMed     Abstract available


  25. SCHINI M, Gossiel F, Paggiosi MA, Hilditch SL, et al
    Randomized controlled trial of an oral Gastrin Receptor Antagonist for the treatment of postmenopausal osteoporosis.
    J Bone Miner Res. 2025 Nov 8:zjaf165. doi: 10.1093.
    PubMed     Abstract available


    October 2025
  26. MOLLER S, Rietz M, Petersen FL, Brond JC, et al
    An enhanced fracture risk evaluation model (FREM) using national health data on morbidity and medications.
    J Bone Miner Res. 2025 Oct 31:zjaf156. doi: 10.1093.
    PubMed     Abstract available


  27. JOHANNESDOTTIR F, Aspelund T, Mahar S, Sigurdsson S, et al
    The relationship between fall risk, trochanteric soft tissue thickness, and hip fracture risk in older adults.
    J Bone Miner Res. 2025 Oct 31:zjaf161. doi: 10.1093.
    PubMed     Abstract available


  28. OSTERTAG A, Leger B, Koumakis E, Fardellone P, et al
    Impaired organic and mineral extracellular matrix composition in early-onset osteoporosis.
    J Bone Miner Res. 2025 Oct 30:zjaf159. doi: 10.1093.
    PubMed     Abstract available


  29. WU Q, Jung J
    Uncovering Racial and Genetic Disparities in FRAX Performance for Fracture Risk Assessment in Postmenopausal Women.
    J Bone Miner Res. 2025 Oct 30:zjaf160. doi: 10.1093.
    PubMed     Abstract available


  30. BONNET AL, Aboishava L, Mannstadt M
    Advances in Parathyroid Hormone-based medicines.
    J Bone Miner Res. 2025;40:1195-1206.
    PubMed     Abstract available


  31. RYHANEN EM, Makitie RE, Pekkarinen T, Kroger H, et al
    Severe early-onset osteoporosis due to heterozygous WNT1 variants in adults: a clinical and therapeutic challenge.
    J Bone Miner Res. 2025 Oct 23:zjaf150. doi: 10.1093.
    PubMed    


  32. RAMCHAND SK, Tsai JN, Zhao Y, Hershman SH, et al
    Comparative Bone Histomorphometry Effects of Combined Denosumab and Teriparatide versus Monotherapy in Postmenopausal Women with Osteoporosis: A Randomized Controlled Trial.
    J Bone Miner Res. 2025 Oct 23:zjaf152. doi: 10.1093.
    PubMed     Abstract available


  33. EBELING PR
    Treat to Target in Osteoporosis - the Time is Right.
    J Bone Miner Res. 2025 Oct 18:zjaf151. doi: 10.1093.
    PubMed    


  34. MITCHELL JA, Bradfield J, McCormack SE, Chesi A, et al
    The gSOS Polygenic Score is Associated with Bone Density and Fracture Risk in Childhood.
    J Bone Miner Res. 2025 Oct 14:zjaf149. doi: 10.1093.
    PubMed     Abstract available


  35. EBELING PR
    Increased Bone Fragility in Diabetes Mellitus.
    J Bone Miner Res. 2025 Oct 13:zjaf147. doi: 10.1093.
    PubMed    


  36. BEYERSDORF C, Maus U, Wiedmann F, Juliana Franziska Bousch J, et al
    Mechanosensitive Ion Channels as Novel Targets in Osteoporosis.
    J Bone Miner Res. 2025 Oct 10:zjaf145. doi: 10.1093.
    PubMed     Abstract available


  37. GEBRE AK, Sim M, Gilani SZ, Saleem A, et al
    Automated abdominal aortic calcification and trabecular bone score independently predict incident fracture during routine osteoporosis screening.
    J Bone Miner Res. 2025 Oct 10:zjaf144. doi: 10.1093.
    PubMed     Abstract available


  38. PRISBY RD
    Bone Loss, Botulinum Toxin, and Cardiovascular Function.
    J Bone Miner Res. 2025 Oct 6:zjaf137. doi: 10.1093.
    PubMed    


  39. ZHYTNIK L, Ventura L, Sclocco A, Verhage M, et al
    New Lens On Congenital Mild Bone Fragility: a Novel Col1a1 Knockout Mouse Model for Osteogenesis Imperfecta Type 1.
    J Bone Miner Res. 2025 Oct 6:zjaf138. doi: 10.1093.
    PubMed     Abstract available


    September 2025

  40. Correction to: Vertebral fracture prevalence and risk factors for fracture in The Gambia, West Africa: the Gambian Bone and Muscle Ageing Study.
    J Bone Miner Res. 2025 Sep 30:zjaf109. doi: 10.1093.
    PubMed    


  41. O BREASAIL M, Zengin A, Pearse C, Drammeh I, et al
    Rural-urban differences in osteoporosis and sarcopenia prevalence among Gambian older adults: A pilot study.
    J Bone Miner Res. 2025 Sep 22:zjaf130. doi: 10.1093.
    PubMed     Abstract available


  42. WILLIE BM, Hosseinitabatabaei S
    Systemic bone loss during fracture healing: new evidence from HR-pQCT analyses.
    J Bone Miner Res. 2025 Sep 19:zjaf073. doi: 10.1093.
    PubMed    


  43. GERALDI MV, Gregori G, Johansson L, Hjertonsson U, et al
    Associations between body composition and bone loss in early postmenopausal women.
    J Bone Miner Res. 2025 Sep 11:zjaf125. doi: 10.1093.
    PubMed     Abstract available


  44. HUININGA K, Koromani F, Zillikens MC, van Velsen EFS, et al
    Use of DXA-derived 3D-modeling, as implemented by 3D-shaper(R), for the assessment of fracture risk in a population-based setting.
    J Bone Miner Res. 2025 Sep 2:zjaf120. doi: 10.1093.
    PubMed     Abstract available


    August 2025
  45. ADAMI G, Montanari F, Fassio A, Pollastri F, et al
    Increase in Serum DKK1 Levels Attenuates the Anabolic Response to Romosozumab in Postmenopausal Osteoporosis.
    J Bone Miner Res. 2025 Aug 19:zjaf110. doi: 10.1093.
    PubMed     Abstract available


  46. SYME CA, Cicero MD, Adachi JD, Berger C, et al
    Fracture Risk Scores Using Output from an Opportunistic Screen of Low Bone Density from Conventional X-ray.
    J Bone Miner Res. 2025 Aug 19:zjaf113. doi: 10.1093.
    PubMed     Abstract available


  47. BUGBIRD AR, Whittier DE, Burt LA, Boyd SK, et al
    Longitudinal Associations Between Changes in Bone Mechanical Strength and Fracture Risk Estimated by FRAC.
    J Bone Miner Res. 2025 Aug 18:zjaf111. doi: 10.1093.
    PubMed     Abstract available


  48. MAEDA M, Saito H, Ribet ABP, Hesse E, et al
    Tgif1-deficiency impairs osteoclast differentiation through PP2A-mediated ERK1/2 dephosphorylation and attenuates bone loss in mice.
    J Bone Miner Res. 2025 Aug 14:zjaf107. doi: 10.1093.
    PubMed     Abstract available


  49. HARVEY NC, Johansson H, McCloskey EV, Liu E, et al
    Body mass index and subsequent fracture risk: A meta-analysis to update FRAX(R).
    J Bone Miner Res. 2025 Aug 8:zjaf091. doi: 10.1093.
    PubMed     Abstract available


  50. SOLOMON DH, Ruppert KM, Lian P, Neal-Perry G, et al
    The Risk of Fracture Among Women Starting Selective Serotonin Reuptake Inhibitors.
    J Bone Miner Res. 2025 Aug 4:zjaf106. doi: 10.1093.
    PubMed     Abstract available


  51. WANG J, Wang Y, Ren J, Li Z, et al
    Emerging Applications of Feature Selection in Osteoporosis Research: From Biomarker Discovery to Clinical Decision Support.
    J Bone Miner Res. 2025 Aug 1:zjaf105. doi: 10.1093.
    PubMed     Abstract available


    July 2025
  52. VILACA T, Lui LY, Schini M, Ewing SK, et al
    Treatment-related changes in total hip bone mineral density are applicable to trials of varied study designs and to drugs with differing mechanisms of action: meta-regression results from the FNIH-ASBMR SABER study.
    J Bone Miner Res. 2025 Jul 26:zjaf100. doi: 10.1093.
    PubMed     Abstract available


  53. KOVACS CS
    Parity and lactation cause transient bone loss but are not risk factors for osteoporosis later in life.
    J Bone Miner Res. 2025 Jul 17:zjaf095. doi: 10.1093.
    PubMed    


  54. CURTIS EM, Moon RJ, D'Angelo S, Raisi-Estabragh Z, et al
    Type 1 and 2 diabetes mellitus: comprehensive fracture risk relationships in UK Biobank.
    J Bone Miner Res. 2025 Jul 11:zjaf094. doi: 10.1093.
    PubMed     Abstract available


    June 2025
  55. JEPSEN KJ, Bredbenner TL, Karvonen-Gutierrez CA, Leis AM, et al
    Femoral neck width is associated with unique trajectories of age-related hip structural changes and fracture risk within populations of adult women and men.
    J Bone Miner Res. 2025 Jun 28:zjaf090. doi: 10.1093.
    PubMed     Abstract available


  56. LI M, Sun H, Liu L, Ning Y, et al
    Pro-Inflammatory Immune Microenvironment and THBS1-Positive Monocytes as Drivers of Osteoclastogenesis in Postmenopausal Osteoporosis.
    J Bone Miner Res. 2025 Jun 14:zjaf083. doi: 10.1093.
    PubMed     Abstract available


  57. KISTLER-FISCHBACHER M, Armbrecht G, Da Silva JAP, Molino CGRC, et al
    Effects of vitamin D3, omega-3 s and a simple home exercise program on incident vertebral fractures: the DO-HEALTH randomized controlled trial.
    J Bone Miner Res. 2025 Jun 10:zjaf058. doi: 10.1093.
    PubMed     Abstract available


  58. JADZIC J, Plumeyer C, Djukic D, Zivkovic V, et al
    Site-specific alterations of bone matrix mineralization, micro-hardness and density of mineralized osteocyte lacunae in men with alcohol-associated liver disease: implications for vertebral fracture predilection.
    J Bone Miner Res. 2025 Jun 6:zjaf065. doi: 10.1093.
    PubMed     Abstract available


    May 2025

  59. Expression of Concern: Comparative cardiovascular safety of romosozumab versus bisphosphonates in Japanese patients with osteoporosis: a new-user, active comparator design with instrumental variable analyses.
    J Bone Miner Res. 2025 May 25:zjaf074. doi: 10.1093.
    PubMed    


  60. ZARZOUR F, Schousboe JT, Binkley N, Hans D, et al
    Proton Pump Inhibitor Exposure, Trabecular Bone Score and Bone Mineral Density: A Registry-Based Cohort Study.
    J Bone Miner Res. 2025 May 14:zjaf072. doi: 10.1093.
    PubMed     Abstract available


  61. BJORNSDOTTIR S, Kamal W, Mannstadt M, Makitie O, et al
    Increased risk of vertebral fractures and reduced risk of femur fractures in patients with chronic hypoparathyroidism: a Nationwide cohort study in Sweden.
    J Bone Miner Res. 2025 May 5:zjaf061. doi: 10.1093.
    PubMed     Abstract available


    April 2025
  62. MOUSSA MS, de Vet T, Lebcir N, Zaslansky P, et al
    Botulinum toxin (a) -induced bone loss is associated with increased blood velocity and reduced vascular bone porosity.
    J Bone Miner Res. 2025 Apr 24:zjaf057. doi: 10.1093.
    PubMed     Abstract available


  63. COSMAN F, Mitlak BH, Wang Y, Pearman L, et al
    Probability of Achieving Bone Mineral Density Treatment Targets with Abaloparatide and Teriparatide.
    J Bone Miner Res. 2025 Apr 11:zjaf053. doi: 10.1093.
    PubMed     Abstract available


  64. HONG N, Cho SW, Lee YH, Kim CO, et al
    Deep learning-based identification of vertebral fracture and osteoporosis in lateral spine radiographs and DXA VFA to predict incident fracture.
    J Bone Miner Res. 2025 Apr 1:zjaf050. doi: 10.1093.
    PubMed     Abstract available


    March 2025
  65. JORGENSEN HS, Evenepoel P
    Osteoporosis after kidney transplantation - no place for active vitamin D in the prevention of bone loss.
    J Bone Miner Res. 2025 Mar 29:zjaf049. doi: 10.1093.
    PubMed    


  66. KUMAR S, Wang M, Kim AS, Center JR, et al
    Denosumab discontinuation in the clinic: implications of rebound bone turnover and emerging strategies to prevent bone loss and fractures.
    J Bone Miner Res. 2025 Mar 9:zjaf037. doi: 10.1093.
    PubMed     Abstract available


  67. MCCLUNG MR
    Sequential Osteoanabolic therapy for osteoporosis.
    J Bone Miner Res. 2025 Mar 5:zjaf033. doi: 10.1093.
    PubMed    


  68. KOBAYAKAWA T, Nakamura Y
    Response to letter to the editor of JBMR: sequential Osteoanabolic therapy for osteoporosis.
    J Bone Miner Res. 2025 Mar 5:zjaf034. doi: 10.1093.
    PubMed    


    February 2025
  69. SCHMIDT C, Woo MS, Alimy AR, Baranowsky A, et al
    Biphasic bone loss in experimental autoimmune encephalomyelitis.
    J Bone Miner Res. 2025 Feb 16:zjaf027. doi: 10.1093.
    PubMed     Abstract available


  70. FOUHY LE, Mangano KM, Zhang X, Hughes BD, et al
    Association between urinary catecholamines and glucocorticoids and bone mineral density and osteoporosis in Puerto Rican adults.
    J Bone Miner Res. 2025 Feb 2:zjaf016. doi: 10.1093.
    PubMed     Abstract available


    January 2025
  71. JAIN RK, Liu JY, Grant RW, Haider S, et al
    Biases in the performance of FRAX without BMD in predicting fracture risk in a multiethnic population with diabetes: the Diabetes & Aging Study.
    J Bone Miner Res. 2025 Jan 29:zjaf012. doi: 10.1093.
    PubMed     Abstract available


  72. ZARZOUR F, Aftabi S, Leslie WD
    Effects of femoral neck width and hip Axis length on incident hip fracture risk: a registry-based cohort study.
    J Bone Miner Res. 2025 Jan 27:zjaf019. doi: 10.1093.
    PubMed     Abstract available


  73. COSMAN F, Wang Z, Li X, Cummings SR, et al
    Probability of Achieving Bone Mineral Density Treatment Goals with Denosumab Treatment in Postmenopausal Women with Osteoporosis.
    J Bone Miner Res. 2025 Jan 25:zjaf014. doi: 10.1093.
    PubMed     Abstract available


  74. DONG Y, Wu X, Hao Y, Liu W, et al
    Epiregulin ameliorates ovariectomy-induced bone loss through orchestrating the differentiation of osteoblasts and osteoclasts.
    J Bone Miner Res. 2025 Jan 25:zjaf017. doi: 10.1093.
    PubMed     Abstract available


  75. KIM AS, Taylor VE, Castro-Martinez A, Dhakal S, et al
    Early and multiple doses of zoledronate mitigates rebound bone loss following withdrawal of RANKL inhibition.
    J Bone Miner Res. 2025 Jan 23:zjaf008. doi: 10.1093.
    PubMed     Abstract available


  76. TOMINAGA R, Ikenoue T, Ishii R, Niihata K, et al
    Comparative cardiovascular safety of romosozumab versus bisphosphonates in Japanese patients with osteoporosis: a new-user, active comparator design with instrumental variable analyses.
    J Bone Miner Res. 2025 Jan 17:zjaf010. doi: 10.1093.
    PubMed     Abstract available


  77. BEGLARIAN E, Chen JC, Li Z, Costello E, et al
    Proteins and pathways involved in inflammation are longitudinally associated with total body bone mineral density among primarily hispanic overweight/obese adolescents and young adults.
    J Bone Miner Res. 2025 Jan 14:zjaf002. doi: 10.1093.
    PubMed     Abstract available


  78. EASTELL R, Brown JP, Adler RA, Lewiecki EM, et al
    Bone Turnover Markers Predict Changes in Bone Mineral Density in Men Treated with Abaloparatide: Results from ATOM.
    J Bone Miner Res. 2025 Jan 10:zjaf003. doi: 10.1093.
    PubMed     Abstract available


  79. SMITH C, Sim M, Ilyas Z, Gilani SZ, et al
    Automated abdominal aortic calcification and major adverse cardiovascular events in people undergoing osteoporosis screening: the Manitoba Bone Mineral Density Registry.
    J Bone Miner Res. 2025 Jan 3:zjae208. doi: 10.1093.
    PubMed     Abstract available


    December 2024
  80. BERTOLDO F, Tripepi G, Zaninotto M, Plebani M, et al
    Possible role of bone turnover markers in the diagnosis of adult hypophosphatasia.
    J Bone Miner Res. 2024;40:79-86.
    PubMed     Abstract available


  81. FERRARI S
    Commentary: Romosozumab following denosumab improves lumbar spine bone mineral density and trabecular bone score greater than denosumab continuation in postmenopausal women.
    J Bone Miner Res. 2024 Dec 10:zjae192. doi: 10.1093.
    PubMed    


  82. KOBAYAKAWA T, Nakamura Y
    Verifying the effectiveness of romosozumab re-administration on bone mineral density.
    J Bone Miner Res. 2024 Dec 6:zjae196. doi: 10.1093.
    PubMed     Abstract available


  83. MCCLUNG MR, Betah D, Leder BZ, Kendler DL, et al
    Romosozumab Improves Microarchitecture as Assessed by Tissue Thickness-Adjusted Trabecular Bone Score in Postmenopausal Women with Osteoporosis.
    J Bone Miner Res. 2024 Dec 5:zjae194. doi: 10.1093.
    PubMed     Abstract available


    November 2024
  84. GLAVAS C, Scott D
    One day at a time: understanding how 24-hour physical activity, sedentary behavior and sleep patterns influence falls and fracture risk.
    J Bone Miner Res. 2024 Nov 19:zjae188. doi: 10.1093.
    PubMed    


  85. WARD KA, Jarjou L, Pearse C, Breasail MO, et al
    Vertebral fracture prevalence and risk factors for fracture in the Gambia, West Africa: the Gambian bone and muscle ageing study.
    J Bone Miner Res. 2024 Nov 7:zjae182. doi: 10.1093.
    PubMed     Abstract available


  86. KOVACS CS
    The challenges of investigating causes and recovery from osteoporosis associated with pregnancy and lactation.
    J Bone Miner Res. 2024 Nov 5:zjae180. doi: 10.1093.
    PubMed    


  87. HONG N, Shin S, Kim H, Cho SJ, et al
    Romosozumab following denosumab improves lumbar spine bone mineral density and trabecular bone score greater than denosumab continuation in postmenopausal women.
    J Bone Miner Res. 2024 Nov 1:zjae179. doi: 10.1093.
    PubMed     Abstract available


    October 2024
  88. AGARWAL S, El-Najjar D, Kondapalli A, Kil N, et al
    HR-pQCT reveals marked trabecular and cortical structural deficits in women with pregnancy and lactation associated osteoporosis (PLO).
    J Bone Miner Res. 2024 Oct 18:zjae167. doi: 10.1093.
    PubMed     Abstract available


  89. YE C, Leslie WD, Bouxsein ML, Dufour AB, et al
    Association of vertebral fractures with worsening degenerative changes of the spine: a longitudinal study.
    J Bone Miner Res. 2024 Oct 17:zjae172. doi: 10.1093.
    PubMed     Abstract available


  90. CHEN L, Xiong L, Guo H, Feng X, et al
    Osteoclastic ATP6AP2 maintains beta-catenin levels to prevent hyper-osteoclastic activation and trabecular bone-loss.
    J Bone Miner Res. 2024 Oct 14:zjae164. doi: 10.1093.
    PubMed     Abstract available


  91. ROSILLO I, Germosen C, Agarwal S, Rawal R, et al
    Patella Fractures are Associated with Bone Fragility - A Retrospective Study.
    J Bone Miner Res. 2024 Oct 10:zjae165. doi: 10.1093.
    PubMed     Abstract available


  92. QUINTIENS J, Coudyzer W, Bevers M, Vereecke E, et al
    The Quantification of Bone Mineral Density Using Photon Counting Computed Tomography and its Implications for Detecting Bone Remodelling.
    J Bone Miner Res. 2024 Oct 4:zjae163. doi: 10.1093.
    PubMed     Abstract available


    September 2024
  93. ROE LS, Strotmeyer ES, Cawthon PM, Glynn NW, et al
    24-Hour Activity Composition is Associated with Lower Fall and Fracture Risk in Older Men.
    J Bone Miner Res. 2024 Sep 30:zjae160. doi: 10.1093.
    PubMed     Abstract available


  94. WALKER MD, Bilezikian JP
    Use of Race and Ethnicity in Fracture Risk Assessment: It is Time for a Re-assessment.
    J Bone Miner Res. 2024 Sep 25:zjae153. doi: 10.1093.
    PubMed    


  95. ADLER RA
    Treating Osteoporosis in Patients with Atypical Femoral Fracture.
    J Bone Miner Res. 2024 Sep 24:zjae150. doi: 10.1093.
    PubMed     Abstract available


  96. JACKSON LE, Saag KG, Johnson SR, Danila MI, et al
    Reply to Ganda and colleagues' letter to the editor regarding "Defining the Key Clinician Skills and Attributes For Competency in Managing Patients with Osteoporosis and Fragility Fractures" by LE Jackson and colleagues.
    J Bone Miner Res. 2024 Sep 17:zjae145. doi: 10.1093.
    PubMed    


  97. GANDA K, Bennett M, Centre J, Daly RM, et al
    Defining the key clinician skills and attributes for competency managing patients with osteoporosis and fragility fractures.
    J Bone Miner Res. 2024 Sep 11:zjae146. doi: 10.1093.
    PubMed    


  98. SARFATI M, Chapurlat R, Dufour AB, Sornay-Rendu E, et al
    Short-term risk of fracture is increased by deficits in cortical and trabecular bone microarchitecture independent of DXA BMD and FRAX: bone microarchitecture international consortium (BoMIC) prospective cohorts.
    J Bone Miner Res. 2024 Sep 5:zjae143. doi: 10.1093.
    PubMed     Abstract available


  99. JAD R, Ma X, Stanojevic S, Illango A, et al
    Longitudinal Changes in Bone Mineral Density in Adults with Cystic Fibrosis.
    J Bone Miner Res. 2024 Sep 2:zjae139. doi: 10.1093.
    PubMed     Abstract available


    August 2024
  100. MADANHIRE T, Breasail MO, Mukwasi-Kahari C, Kowo-Nyakoko F, et al
    Prevalence of HIV-associated osteoporosis and fracture risk in mid-life women: a cross-sectional study in Zimbabwe.
    J Bone Miner Res. 2024 Aug 24:zjae138. doi: 10.1093.
    PubMed     Abstract available


  101. SU KJ, Qiu C, Greenbaum J, Zhang X, et al
    Genomic structural variations link multiple genes to bone mineral density in a multi-ethnic cohort study: Louisiana osteoporosis study.
    J Bone Miner Res. 2024 Aug 21:zjae133. doi: 10.1093.
    PubMed     Abstract available


  102. GATINEAU G, Shevroja E, Vendrami C, Rodriguez EG, et al
    Development and reporting of artificial intelligence in osteoporosis management.
    J Bone Miner Res. 2024 Aug 20:zjae131. doi: 10.1093.
    PubMed     Abstract available


  103. BURNETT-BOWIE SM, Wright NC, Yu EW, Langsetmo L, et al
    Response to the letter to the editor regarding "The American Society for Bone and Mineral Research Task Force on clinical algorithms for fracture risk report".
    J Bone Miner Res. 2024 Aug 11:zjae111. doi: 10.1093.
    PubMed    


  104. QIN C, Zhang W, Xiao C, Qu Y, et al
    Shared genetic basis connects smoking behaviors and bone health: insights from a genome-wide cross-trait analysis.
    J Bone Miner Res. 2024;39:918-928.
    PubMed     Abstract available


  105. VILACA T, Schini M, Lui LY, Ewing SK, et al
    The relationship between treatment-related changes in total hip bone mineral density measured after 12, 18 and 24 months and fracture risk reduction in osteoporosis clinical trials: the FNIH-ASBMR-SABRE Project.
    J Bone Miner Res. 2024 Aug 4:zjae126. doi: 10.1093.
    PubMed     Abstract available


    July 2024
  106. COSMAN F, Lewiecki EM, Eastell R, Ebeling PR, et al
    Goal-Directed Osteoporosis Treatment: ASBMR/BHOF Task Force Position Statement 2024.
    J Bone Miner Res. 2024 Jul 29:zjae119. doi: 10.1093.
    PubMed     Abstract available


  107. HAYES KN, Oganisian A, Kiel DP
    Improving the value and interpretation of observational studies comparing treatment effects of osteoporosis medications depends on standardized reporting of methods.
    J Bone Miner Res. 2024 Jul 27:zjae099. doi: 10.1093.
    PubMed    


  108. DAWSON-HUGHES B, Cosman F, McClung M
    Letter to the editor regarding "The American Society for Bone and Mineral Research Task Force on clinical algorithms for fracture risk report".
    J Bone Miner Res. 2024 Jul 22:zjae107. doi: 10.1093.
    PubMed    


  109. CHAVASSIEUX P, Roux JP, Libanati C, Shi Y, et al
    Evaluation of Romosozumab's Effects on Bone Marrow Adiposity in Postmenopausal Osteoporotic Women: Results from the FRAME Bone Biopsy Sub-Study.
    J Bone Miner Res. 2024 Jul 18:zjae118. doi: 10.1093.
    PubMed     Abstract available


  110. PATEL R, Judge A, Johansen A, Javaid MK, et al
    Following hip fracture, hospital organisational factors associated with prescription of anti-osteoporosis medication on discharge, to address imminent refracture risk: a record-linkage study.
    J Bone Miner Res. 2024 Jul 11:zjae100. doi: 10.1093.
    PubMed     Abstract available


  111. CENTER JR, Eisman JA
    Femoral neck width and hip fracture risk.
    J Bone Miner Res. 2024 Jul 11:zjae113. doi: 10.1093.
    PubMed    


  112. ANASTASILAKIS AD, Polyzos SA, Makras P, Savvidis M, et al
    The comparative effect of teriparatide and denosumab on activins, follistatins and inhibins in women with postmenopausal osteoporosis.
    J Bone Miner Res. 2024 Jul 8:zjae106. doi: 10.1093.
    PubMed     Abstract available


    June 2024
  113. KEAVENY TM, Adams AL, Orwoll ES, Khosla S, et al
    Osteoporosis treatment prevents hip fracture similarly in both sexes: the FOCUS observational study.
    J Bone Miner Res. 2024 Jun 11:zjae090. doi: 10.1093.
    PubMed     Abstract available


    May 2024
  114. SCHINI M, Vilaca T, Vittinghoff E, Lui LY, et al
    Influence of age on the efficacy of pharmacologic treatments on fracture risk reduction and increases in BMD: RCT results from the FNIH-ASBMR-SABRE project.
    J Bone Miner Res. 2024;39:544-550.
    PubMed     Abstract available



  115. Correction to: Equivalence trial of proposed denosumab biosimilar GP2411 and reference denosumab in postmenopausal osteoporosis: the ROSALIA study.
    J Bone Miner Res. 2024 May 22:zjae077. doi: 10.1093.
    PubMed    


  116. CURTIS JR, Arora T, Liu Y, Lin TC, et al
    Comparative effectiveness of Denosumab vs alendronate among postmenopausal women with osteoporosis.
    J Bone Miner Res. 2024 May 16:zjae079. doi: 10.1093.
    PubMed     Abstract available


  117. LIN YJ, Liang WM, Chiou JS, Chou CH, et al
    Genetic predisposition to bone mineral density and their health conditions in East Asians.
    J Bone Miner Res. 2024 May 16:zjae078. doi: 10.1093.
    PubMed     Abstract available


  118. RODRIGUEZ-SOSA MR, Del Castillo LM, Belarra A, Zapata AG, et al
    The lack of EphB3 receptor prevents bone loss in mouse models of osteoporosis.
    J Bone Miner Res. 2024 May 13:zjae075. doi: 10.1093.
    PubMed     Abstract available


  119. LESLIE WD, Binkley N, Schousboe JT, Silva BC, et al
    Effect of Abdominal Tissue Thickness on Trabecular Bone Score and Fracture Risk in Adults With Diabetes: The Manitoba BMD Registry.
    J Bone Miner Res. 2024 May 13:zjae073. doi: 10.1093.
    PubMed     Abstract available


  120. PARK C, Kim C, Park RW, Jeon JY, et al
    Comparative Effectiveness and Safety Outcomes Between Denosumab and Bisphosphonate in South Korea.
    J Bone Miner Res. 2024 May 9:zjae070. doi: 10.1093.
    PubMed     Abstract available


  121. PAL R, Banerjee M, Prasad TN, Walia R, et al
    Fracture risk and bone health in adrenal adenomas with mild autonomous cortisol secretion/subclinical Hypercortisolism: a systematic review, meta-analysis and meta-regression.
    J Bone Miner Res. 2024 May 4:zjae067. doi: 10.1093.
    PubMed     Abstract available


  122. SCHOUSBOE JT, Lewis JR, Monchka BA, Reid SB, et al
    Simultaneous automated ascertainment of prevalent vertebral fracture and abdominal aortic calcification in clinical practice: role in fracture risk assessment.
    J Bone Miner Res. 2024 May 3:zjae066. doi: 10.1093.
    PubMed     Abstract available


  123. ABRAHAMSEN B
    Treating osteoporosis in the oldest old.
    J Bone Miner Res. 2024 May 2:zjae045. doi: 10.1093.
    PubMed    


  124. SCHINI M, Vilaca T, Lui LY, Ewing SK, et al
    Pre-treatment bone mineral density (BMD) and the benefit of pharmacologic treatment on fracture risk and BMD change: analysis from the FNIH-ASBMR SABRE project.
    J Bone Miner Res. 2024 May 1:zjae068. doi: 10.1093.
    PubMed     Abstract available


    April 2024
  125. TAO L, Jiang W, Li H, Wang X, et al
    Single-cell RNA sequencing reveals that an imbalance in monocyte subsets rather than changes in gene expression patterns is a feature of postmenopausal osteoporosis.
    J Bone Miner Res. 2024 Apr 23:zjae065. doi: 10.1093.
    PubMed     Abstract available


  126. MOON RJ, Harvey NC
    Smoking in pregnancy increases offspring fracture risk: yet another reason to encourage smoking cessation.
    J Bone Miner Res. 2024 Apr 19:zjae009. doi: 10.1093.
    PubMed    


  127. DUAN JY, You RX, Zhou Y, Xu F, et al
    Assessment of causal association between the socio-economic status and osteoporosis and fractures: a bidirectional Mendelian randomization study in European population.
    J Bone Miner Res. 2024 Apr 16:zjae060. doi: 10.1093.
    PubMed     Abstract available


  128. TAN EH, Rathod-Mistry T, Strauss VY, O'Kelly J, et al
    Evaluating the comparability of osteoporosis treatments using propensity score and negative control outcome methods in UK and Denmark electronic health record databases.
    J Bone Miner Res. 2024 Apr 15:zjae059. doi: 10.1093.
    PubMed     Abstract available


  129. JERBAN S, Ma Y, Wei Z, Shen M, et al
    Ultrashort echo time MRI detects significantly lower collagen but higher pore water in the tibial cortex of female patients with osteopenia and osteoporosis.
    J Bone Miner Res. 2024 Apr 9:zjae053. doi: 10.1093.
    PubMed     Abstract available


  130. BURNETT-BOWIE SM, Wright NC, Yu EW, Langsetmo L, et al
    The American Society for Bone and Mineral Research Task Force on clinical algorithms for fracture risk report.
    J Bone Miner Res. 2024 Apr 9:zjae048. doi: 10.1093.
    PubMed     Abstract available


  131. TRIPTO-SHKOLNIK L, Szalat A, Tsvetov G, Rouach V, et al
    Oral daily PTH(1-34) tablets (EB613) in postmenopausal women with low BMD or osteoporosis: a randomized, placebo-controlled, six-month, phase 2 study.
    J Bone Miner Res. 2024 Apr 5:zjae057. doi: 10.1093.
    PubMed     Abstract available


    March 2024
  132. SHAH VN, Leslie WD, Lautatzis ME, Liu K, et al
    Maternal diabetes and fracture risk in offspring: a population-based analysis.
    J Bone Miner Res. 2024 Mar 28:zjae052. doi: 10.1093.
    PubMed     Abstract available


  133. JORGENSEN HS, Moe S, Nickolas TL
    Diagnosis and therapeutic decisions of osteoporosis in chronic kidney disease.
    J Bone Miner Res. 2024 Mar 17:zjae062. doi: 10.1093.
    PubMed    


  134. FOUHY LE, Lai CQ, Parnell LD, Tucker KL, et al
    Genome-wide association study of osteoporosis identifies genetic risk and interactions with DASH diet and sugar sweetened beverages in a Hispanic cohort of older adults.
    J Bone Miner Res. 2024 Mar 14:zjae047. doi: 10.1093.
    PubMed     Abstract available


  135. PARK HS, Kim K, Yu MH, Shin HY, et al
    Risk of Fracture in Patients with Myasthenia Gravis: A Nationwide Cohort Study in Korea.
    J Bone Miner Res. 2024 Mar 12:zjae043. doi: 10.1093.
    PubMed     Abstract available


  136. LUI DTW, Xiong X, Cheung CL, Lai FTT, et al
    Risks of incident major osteoporotic fractures following SARS-CoV-2 infection among older individuals: a population-based cohort study in Hong Kong.
    J Bone Miner Res. 2024 Mar 9:zjae041. doi: 10.1093.
    PubMed     Abstract available


  137. GAI S, Qian Y, Zhang Z, Zheng HF, et al
    Integrating both common and rare variants to predict bone mineral density and fracture.
    J Bone Miner Res. 2024 Mar 5:zjad022. doi: 10.1093.
    PubMed    


  138. KOVACS CS
    Osteoporosis presenting during pregnancy and lactation: wait and reassess.
    J Bone Miner Res. 2024 Mar 4:zjae038. doi: 10.1093.
    PubMed     Abstract available


  139. BUGBIRD AR, Whittier DE, Boyd SK
    Transferability of bone phenotyping and fracture risk assessment by muFRAC from first-generation high-resolution peripheral quantitative computed tomography to second-generation scan data.
    J Bone Miner Res. 2024 Mar 4:zjae039. doi: 10.1093.
    PubMed     Abstract available


  140. BOYD SK, Manske SL, Matheson B, Smith A, et al
    Letter to the Editor regarding "Opportunistic screening with CT: comparison of phantomless BMD calibration methods".
    J Bone Miner Res. 2024;39:76-77.
    PubMed    


  141. MINISOLA S, Cipriani C, Colangelo L, Pepe J, et al
    Bone loss after discontinuation of denosumab: the devil is in the details.
    J Bone Miner Res. 2024;39:3-7.
    PubMed     Abstract available


  142. YE C, Schousboe JT, Morin SN, Lix LM, et al
    FRAX predicts cardiovascular risk in women undergoing osteoporosis screening: the Manitoba bone mineral density registry.
    J Bone Miner Res. 2024;39:30-38.
    PubMed     Abstract available


  143. BROWN J, Paggiosi MA, Rathbone E, Gregory W, et al
    Prolonged bone health benefits for breast cancer patients following adjuvant bisphosphonate therapy: the BoHFAB study.
    J Bone Miner Res. 2024;39:8-16.
    PubMed     Abstract available


  144. SZULC P, Dufour AB, Hannan MT, Kiel DP, et al
    Fracture risk based on HR-pQCT measures does not vary with age in older adults - the bone microarchitecture international consortium (BoMIC) prospective cohort study.
    J Bone Miner Res. 2024 Mar 3:zjae033. doi: 10.1093.
    PubMed     Abstract available


    February 2024
  145. CAI L, Lv X, Li X, Wang X, et al
    Association of White Matter Hyperintensities with bone mineral density, incident fractures and falls in the UK biobank cohort.
    J Bone Miner Res. 2024 Feb 21:zjae031. doi: 10.1093.
    PubMed     Abstract available


  146. GANDHAM A, Gregori G, Johansson L, Johansson H, et al
    Sarcopenia definitions and their association with fracture risk in older Swedish women.
    J Bone Miner Res. 2024 Feb 9:zjae026. doi: 10.1093.
    PubMed     Abstract available


  147. QIU S, Dhaliwal R, Divine G, Warner E, et al
    Differences in bone histomorphometry between white postmenopausal women with and without atypical femoral fracture after long-term bisphosphonate therapy.
    J Bone Miner Res. 2024 Feb 5:zjae018. doi: 10.1093.
    PubMed     Abstract available


  148. WU Q, Dai J
    Enhanced osteoporotic fracture prediction in postmenopausal women using Bayesian optimization of machine learning models with genetic risk score.
    J Bone Miner Res. 2024 Feb 4:zjae025. doi: 10.1093.
    PubMed     Abstract available


  149. HSU S, Bansal N, Denburg M, Ginsberg C, et al
    Risk factors for hip and vertebral fractures in chronic kidney disease: the CRIC study.
    J Bone Miner Res. 2024 Feb 4:zjae021. doi: 10.1093.
    PubMed     Abstract available


  150. LU H, Lary CW, Hodonsky CJ, Peyser PA, et al
    Association between bone mineral density and coronary artery calcification: an observational and Mendelian randomization study.
    J Bone Miner Res. 2024 Feb 4:zjae022. doi: 10.1093.
    PubMed     Abstract available


  151. JACKSON LE, Saag KG, Johnson SR, Danila MI, et al
    Defining the key clinician skills and attributes for competency in managing patients with osteoporosis and fragility fractures.
    J Bone Miner Res. 2024 Feb 2:zjae019. doi: 10.1093.
    PubMed     Abstract available


    January 2024
  152. JEKA S, Dokoupilova E, Kivitz A, Zuchowski P, et al
    Equivalence trial of proposed denosumab biosimilar GP2411 and reference denosumab in postmenopausal osteoporosis: the ROSALIA study.
    J Bone Miner Res. 2024 Jan 29:zjae016. doi: 10.1093.
    PubMed     Abstract available


  153. MONTGOMERY G, Yusuf M, Cooper R, Ireland A, et al
    Are associations between physical activity and bone mineral density in adults sex- and age-dependent? An analysis of the UK biobank study.
    J Bone Miner Res. 2024 Jan 29:zjae017. doi: 10.1093.
    PubMed     Abstract available


  154. YOSHIDA S, Ikedo A, Yanagihara Y, Sakaue T, et al
    Bub1 suppresses inflammatory arthritis-associated bone loss in mice through inhibition of TNFalpha-mediated osteoclastogenesis.
    J Bone Miner Res. 2024 Jan 27:zjae015. doi: 10.1093.
    PubMed     Abstract available


  155. GUETHMUNDSDOTTIR SL, Berger C, Macdonald H, Adachi JD, et al
    Sedentary behavior does not predict low BMD nor fracture - population-based Canadian Multicentre Osteoporosis Study (CaMos).
    J Bone Miner Res. 2024 Jan 24:zjae004. doi: 10.1093.
    PubMed     Abstract available


  156. MIDDELKOOP K, Micklesfield LK, Walker N, Stewart J, et al
    Influence of vitamin D supplementation on bone mineral content, bone turnover markers and fracture risk in south African schoolchildren: multicentre double-blind randomised placebo-controlled trial (ViDiKids).
    J Bone Miner Res. 2024 Jan 10:zjae007. doi: 10.1093.
    PubMed     Abstract available


    November 2023
  157. BARTENSCHLAGER S, Cavallaro A, Pogarell T, Chaudry O, et al
    Opportunistic Screening With CT: Comparison of Phantomless BMD Calibration Methods.
    J Bone Miner Res. 2023;38:1689-1699.
    PubMed     Abstract available


  158. TRAN TS, Ho-Le TP, Bliuc D, Center JR, et al
    Prevention of Hip Fractures: Trade-off between Minor Benefits to Individuals and Large Benefits to the Community.
    J Bone Miner Res. 2023;38:1594-1602.
    PubMed     Abstract available


    October 2023
  159. ZHANG X, Krishnamoorthy S, Tang CT, Hsu WW, et al
    Association of Bone Mineral Density and Bone Turnover Markers with the Risk of Diabetes: Hong Kong Osteoporosis Study and Mendelian Randomization.
    J Bone Miner Res. 2023 Oct 18. doi: 10.1002/jbmr.4924.
    PubMed     Abstract available


  160. LU T, Forgetta V, Zhou S, Richards JB, et al
    Identifying rare genetic determinants for improved polygenic risk prediction of bone mineral density and fracture risk.
    J Bone Miner Res. 2023 Oct 13. doi: 10.1002/jbmr.4920.
    PubMed     Abstract available


  161. DALLA VIA J, Gebre AK, Smith C, Gilani Z, et al
    Machine-learning assessed abdominal aortic calcification is associated with long-term fall and fracture risk in community-dwelling older Australian women.
    J Bone Miner Res. 2023 Oct 12. doi: 10.1002/jbmr.4921.
    PubMed     Abstract available


  162. DIEZ-PEREZ A, Cordomi CT, Fink Eriksen E, Pasco JA, et al
    Increased BMSi Association With Risk of Incident Osteoporotic Fractures.
    J Bone Miner Res. 2023;38:1541-1542.
    PubMed    


    September 2023
  163. NICOLAES J, Skjodt MK, Raeymaeckers S, Smith CD, et al
    Towards improved identification of vertebral fractures in routine CT scans: development and external validation of a machine learning algorithm.
    J Bone Miner Res. 2023 Sep 25. doi: 10.1002/jbmr.4916.
    PubMed     Abstract available


  164. LORENTZON M, Burghardt AJ
    The Added Value of High-Resolution Peripheral Quantitative Computed Tomography in Fracture Risk Prediction.
    J Bone Miner Res. 2023 Sep 13. doi: 10.1002/jbmr.4909.
    PubMed    


  165. SHOUNG A, Shoung N, Hii R, Nerlekar N, et al
    Electrocardiogram Changes Following Intravenous Bisphosphonate Infusion: A Systematic Review and Meta-Analysis.
    J Bone Miner Res. 2023 Sep 8. doi: 10.1002/jbmr.4911.
    PubMed     Abstract available


  166. GRASSI L, Vaananen SP, Jehpsson L, Ljunggren O, et al
    3D Finite Element Models Reconstructed From 2D Dual-Energy X-Ray Absorptiometry (DXA) Images Improve Hip Fracture Prediction Compared to Areal BMD in Osteoporotic Fractures in Men (MrOS) Sweden Cohort.
    J Bone Miner Res. 2023;38:1258-1267.
    PubMed     Abstract available


    August 2023
  167. JAISWAL R, Zoulakis M, Axelsson KF, Sundh D, et al
    Reply to the Submitted Comment Regarding our Publication "Increased Bone Material Strength Index Is Positively Associated With the Risk of Incident Osteoporotic Fractures in Older Swedish Women".
    J Bone Miner Res. 2023 Aug 31. doi: 10.1002/jbmr.4903.
    PubMed    


  168. QU Y, Xiao C, Wu X, Zhu J, et al
    Genetic correlation, shared loci and causal association between sex hormone-binding globulin and bone mineral density: insights from a large-scale genome-wide cross-trait analysis.
    J Bone Miner Res. 2023 Aug 24. doi: 10.1002/jbmr.4904.
    PubMed     Abstract available


  169. HUGHES JM, Greeves JP
    Editorial on: Association between Combat-Related Traumatic Injury and Skeletal Health: Bone Mineral Density Loss Is Localized and Correlates with Altered Loading in Amputees: The ADVANCE Study.
    J Bone Miner Res. 2023 Aug 22. doi: 10.1002/jbmr.4891.
    PubMed    


  170. FINK HA, Butler ME, Claussen AM, Collins ES, et al
    Performance of Fracture Risk Assessment Tools by Race and Ethnicity: A Systematic Review for the ASBMR Task Force on Clinical Algorithms for Fracture Risk.
    J Bone Miner Res. 2023 Aug 19. doi: 10.1002/jbmr.4895.
    PubMed     Abstract available


  171. SOEBY M, Gribsholt SB, Clausen L, Richelsen B, et al
    Fracture risk in patients with anorexia nervosa over a 40-year period.
    J Bone Miner Res. 2023 Aug 14. doi: 10.1002/jbmr.4901.
    PubMed     Abstract available


  172. SING CW, Lin TC, Bartholomew S, Bell JS, et al
    Global Epidemiology of Hip Fractures: Secular Trends in Incidence Rate, Post-Fracture Treatment, and All-Cause Mortality.
    J Bone Miner Res. 2023;38:1064-1075.
    PubMed     Abstract available


    July 2023
  173. PAN KS, Taylor J, Szymczuk V, Boyce AM, et al
    Lesion expansion in gnathic fibrous dysplasia: natural history, indicators of progression, and response to bisphosphonates.
    J Bone Miner Res. 2023 Jul 21. doi: 10.1002/jbmr.4886.
    PubMed     Abstract available


  174. KLINE GA, Morin SN, Lix LM, Leslie WD, et al
    A population-based registry study of extended bisphosphonate use: minimal shift after landmark publications about shorter treatment duration.
    J Bone Miner Res. 2023 Jul 18. doi: 10.1002/jbmr.4885.
    PubMed     Abstract available


  175. JAUFFRET C, Perichon R, Lamer A, Cortet B, et al
    Association between sarcopenia and fracture risk in a population from the UK Biobank database.
    J Bone Miner Res. 2023 Jul 17. doi: 10.1002/jbmr.4884.
    PubMed     Abstract available


  176. SHEN L, Gao C, Hu S, Kang D, et al
    Using Artificial Intelligence to Diagnose Osteoporotic Vertebral Fractures on Plain Radiographs.
    J Bone Miner Res. 2023 Jul 14. doi: 10.1002/jbmr.4879.
    PubMed     Abstract available


  177. DAI H, Zheng L, Zhu Z, Geng X, et al
    Evaluation of the effect of sodium-glucose cotransporter 2 inhibition on fracture risk: evidence from Mendelian randomization and genetic association study.
    J Bone Miner Res. 2023 Jul 12. doi: 10.1002/jbmr.4880.
    PubMed     Abstract available


  178. LEWIECKI EM, Czerwinski E, Recknor C, Strzelecka A, et al
    Efficacy and safety of transdermal abaloparatide in postmenopausal women with osteoporosis: a randomized study.
    J Bone Miner Res. 2023 Jul 7. doi: 10.1002/jbmr.4877.
    PubMed     Abstract available


  179. BURT LA, Kaufmann M, Rose MS, Jones G, et al
    Measurements of the Vitamin D Metabolome in the Calgary Vitamin D Study: Relationship of Vitamin D Metabolites to Bone Loss.
    J Bone Miner Res. 2023 Jul 6. doi: 10.1002/jbmr.4876.
    PubMed     Abstract available


  180. XIE Y, Bao Z, Wang Z, Du D, et al
    Magnesium Ascorbyl Phosphate Promotes Bone Formation Via CaMKII Signaling.
    J Bone Miner Res. 2023;38:1015-1031.
    PubMed     Abstract available


    June 2023
  181. KIRK B, Harrison SL, Zanker J, Burghardt AJ, et al
    Interactions between HR-pQCT bone density and D(3) Cr muscle mass (or HR-pQCT bone structure and HR-pQCT muscle density) in predicting fractures: The Osteoporotic Fractures in Men study.
    J Bone Miner Res. 2023 Jun 23. doi: 10.1002/jbmr.4874.
    PubMed     Abstract available


  182. QI W, Mei Z, Sun Z, Lin C, et al
    Exposure to multiple air pollutants and the risk of fractures: a large prospective population-based study.
    J Bone Miner Res. 2023 Jun 21. doi: 10.1002/jbmr.4872.
    PubMed     Abstract available


  183. AHN SH, Lee YJ, Hong S, Park JW, et al
    Risk of fractures in thyroid cancer patients with postoperative hypoparathyroidism: A nationwide cohort study in Korea.
    J Bone Miner Res. 2023 Jun 20. doi: 10.1002/jbmr.4871.
    PubMed     Abstract available


  184. HALTON JM, Ma J, Babyn P, Matzinger MA, et al
    Reductions in Bone Mineral Density are Apparent Early in Children with Prevalent Osteonecrosis Lesions Following Leukemia Therapy.
    J Bone Miner Res. 2023 Jun 16. doi: 10.1002/jbmr.4870.
    PubMed     Abstract available


  185. HORNICK MA, Van Name M
    Decreased Bone Density and Strength in Young People After Bariatric Surgery: How Much Matters?
    J Bone Miner Res. 2023 Jun 14. doi: 10.1002/jbmr.4831.
    PubMed    



  186. Correction to "Durability and Delayed Treatment Effects of Zoledronic Acid on Bone Loss after Spinal Cord Injury: A Randomized, Controlled Trial".
    J Bone Miner Res. 2023 Jun 12. doi: 10.1002/jbmr.4864.
    PubMed    


    May 2023
  187. SU YH, Chien KL, Yang SH, Chia WT, et al
    Nonalcoholic fatty liver disease is associated with decreased bone mineral density in adults: A systematic review and meta-analysis.
    J Bone Miner Res. 2023 May 30. doi: 10.1002/jbmr.4862.
    PubMed     Abstract available


  188. MCMENEMY L, Behan FP, Kaufmann J, Cain D, et al
    Association Between Combat-Related Traumatic Injury and Skeletal Health: Bone Mineral Density Loss Is Localized and Correlates With Altered Loading in Amputees: the Armed Services Trauma Rehabilitation Outcome (ADVANCE) Study.
    J Bone Miner Res. 2023 May 17. doi: 10.1002/jbmr.4794.
    PubMed     Abstract available


  189. HONG N, Burm SW, Kim HC, Kim CO, et al
    Jump power predicts fracture risk in older adults independent of sarcopenia and FRAX.
    J Bone Miner Res. 2023 May 16. doi: 10.1002/jbmr.4825.
    PubMed     Abstract available


  190. WHITTIER DE, Samelson EJ, Hannan MT, Burt LA, et al
    A Fracture Risk Assessment Tool for High Resolution Peripheral Quantitative Computed Tomography.
    J Bone Miner Res. 2023 May 3. doi: 10.1002/jbmr.4808.
    PubMed     Abstract available


  191. HASSAN N, Gregson CL, Tang H, van der Kamp M, et al
    Rare and Common Variants in GALNT3 May Affect Bone Mass Independently of Phosphate Metabolism.
    J Bone Miner Res. 2023;38:678-691.
    PubMed     Abstract available


  192. TAN J, Ng CA, Hart NH, Rantalainen T, et al
    Reduced Peak Bone Mass in Young Adults With Low Motor Competence.
    J Bone Miner Res. 2023;38:665-677.
    PubMed     Abstract available


    April 2023
  193. KIM M, Lin TC, Arora T, Zhao H, et al
    Comparability of Osteoporosis Treatment Groups Among Female Medicare Beneficiaries in the United States.
    J Bone Miner Res. 2023 Apr 23. doi: 10.1002/jbmr.4817.
    PubMed     Abstract available


  194. JAISWAL R, Zoulakis M, Axelsson KF, Darelid A, et al
    Increased bone material strength index is positively associated with the risk of incident osteoporotic fractures in older Swedish women.
    J Bone Miner Res. 2023 Apr 23. doi: 10.1002/jbmr.4816.
    PubMed     Abstract available


  195. HONG N, Cho SW, Shin S, Lee S, et al
    Deep-learning-based detection of vertebral fracture and osteoporosis using lateral spine X-ray radiography.
    J Bone Miner Res. 2023 Apr 10. doi: 10.1002/jbmr.4814.
    PubMed     Abstract available


  196. LESLIE WD, Goel H, Binkley N, McCloskey EV, et al
    Contributions of Clinical and Technical Factors to Longitudinal Change in Trabecular Bone Score and Bone Density: A Registry-Based Individual-Level Analysis.
    J Bone Miner Res. 2023;38:512-521.
    PubMed     Abstract available


    March 2023
  197. SIMIC MK, Mohanty ST, Xiao Y, Cheng TL, et al
    Multi-targeting DKK1 and LRP6 Prevents Bone Loss and Improves Fracture Resistance in Multiple Myeloma.
    J Bone Miner Res. 2023 Mar 29. doi: 10.1002/jbmr.4809.
    PubMed     Abstract available


  198. GUNSING E, Wagner PP, Whittier DE, Boyd SK, et al
    Rapid cortical bone loss at the distal radius is associated with higher risk of fracture in older men - the STRAMBO study.
    J Bone Miner Res. 2023 Mar 29. doi: 10.1002/jbmr.4811.
    PubMed     Abstract available


  199. YOSIBASH Z, Trabelsi N, Buchnik I, Myers KW, et al
    Hip fracture risk assessment in elderly and diabetic patients: combining autonomous finite element analysis and machine learning.
    J Bone Miner Res. 2023 Mar 27. doi: 10.1002/jbmr.4805.
    PubMed     Abstract available


  200. AXELSSON KF, Litsne H, Lorentzon M
    The Importance of Recent Prevalent Fracture Site For Imminent Risk of Fracture - a Retrospective, Nationwide Cohort Study of Older Swedish Men and Women.
    J Bone Miner Res. 2023 Mar 27. doi: 10.1002/jbmr.4806.
    PubMed     Abstract available


  201. DONG H, Liu R, Zou K, Jin Z, et al
    Higenamine Promotes Osteogenesis via IQGAP1/SMAD4 Signaling Pathway and Prevents Age- and Estrogen-Dependent Bone Loss in Mice.
    J Bone Miner Res. 2023 Mar 12. doi: 10.1002/jbmr.4800.
    PubMed     Abstract available


  202. FUSARO M, Tripepi G
    Romosozumab Use and Cardiovascular Events.
    J Bone Miner Res. 2023;38:452-453.
    PubMed    


    February 2023
  203. GOBRON B, Couchot M, Irwin N, Legrand E, et al
    Development of a first-in-class unimolecular dual GIP/GLP-2 analogue, GL-0001, for the treatment of bone fragility.
    J Bone Miner Res. 2023 Feb 27. doi: 10.1002/jbmr.4792.
    PubMed     Abstract available


    September 2021
  204. HONG N, Park H, Kim CO, Kim HC, et al
    Bone Radiomics Score Derived From DXA Hip Images Enhances Hip Fracture Prediction in Older Women.
    J Bone Miner Res. 2021;36:1708-1716.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Osteoporosis is free of charge.

Privacy / Datenschutzerklärung | Imprint / Impressum